在过去的 20 年里，我们从卡介苗接种中学到了什么，这些知识能帮助我们设计出更好的结核病疫苗吗？
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
机构信息
Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
出版信息
Vaccine. 2022 Mar 8;40(11):1525-1533. doi: 10.1016/j.vaccine.2021.01.068. Epub 2021 Feb 12.
Abstract
The BCG vaccine will, in 2021, have been in use for 100 years. Much remains to be understood, including the reasons for its variable efficacy against pulmonary tuberculosis in adults. This review will discuss what has been learnt about the BCG vaccine in the last two decades, and whether this new information can be exploited to improve its efficacy, by enhancing its ability to induce either antigen-specific and/or non-specific effects. Many factors affect both the immunogenicity of BCG and its protective efficacy, highlighting the challenges of working with a live vaccine in man, but new insights may enable us to exploit better what BCG can do.
摘要
卡介苗（BCG）疫苗将于 2021 年使用 100 年。仍有许多方面需要了解，包括其对成人肺结核的疗效为何存在差异。本综述将讨论在过去二十年中对卡介苗的了解，以及这些新信息是否可以通过增强其诱导抗原特异性和/或非特异性作用的能力来提高其疗效。许多因素影响卡介苗的免疫原性及其保护效力，这突出了在人体中使用活疫苗的挑战，但新的见解可能使我们能够更好地利用卡介苗所能发挥的作用。
相似文献
1
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?在过去的 20 年里，我们从卡介苗接种中学到了什么，这些知识能帮助我们设计出更好的结核病疫苗吗？
Vaccine. 2022 Mar 8;40(11):1525-1533. doi: 10.1016/j.vaccine.2021.01.068. Epub 2021 Feb 12.
2
[Novel vaccines against M. tuberculosis].[新型抗结核分枝杆菌疫苗]
Kekkaku. 2006 Dec;81(12):745-51.
3
Current status of new tuberculosis vaccine in children.儿童新型结核病疫苗的现状
Hum Vaccin Immunother. 2016 Apr 2;12(4):960-70. doi: 10.1080/21645515.2015.1120393. Epub 2016 Mar 22.
4
Recent developments in tuberculosis vaccines.结核病疫苗的最新进展
Curr Opin Infect Dis. 2005 Jun;18(3):211-5. doi: 10.1097/01.qco.0000168380.08895.9a.
5
AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.AdHu5Ag85A呼吸道黏膜加强免疫增强卡介苗初免非人灵长类动物对肺结核的保护作用。
PLoS One. 2015 Aug 7;10(8):e0135009. doi: 10.1371/journal.pone.0135009. eCollection 2015.
6
BCG-mediated protection against M. tuberculosis is sustained post-malaria infection independent of parasite virulence.卡介苗介导的针对结核分枝杆菌的保护作用在疟疾感染后持续存在，且与寄生虫毒力无关。
Immunology. 2022 Feb;165(2):219-233. doi: 10.1111/imm.13431. Epub 2021 Dec 6.
7
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.减毒活结核分枝杆菌疫苗 MTBVAC 与卡介苗在成人和新生儿中的比较：一项随机对照、双盲剂量递增试验。
Lancet Respir Med. 2019 Sep;7(9):757-770. doi: 10.1016/S2213-2600(19)30251-6. Epub 2019 Aug 12.
8
Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.针对肺结核的免疫策略：T 细胞地理学的考虑。
Adv Exp Med Biol. 2013;783:267-78. doi: 10.1007/978-1-4614-6111-1_14.
9
Natural and trained innate immunity against Mycobacterium tuberculosis.天然和训练有素的固有免疫对抗结核分枝杆菌。
Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27.
10
Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.新型候选疫苗结核分枝杆菌ΔmosR和ΔechA7对结核分枝杆菌北京菌株攻击的保护作用。
Vaccine. 2015 Oct 13;33(42):5633-5639. doi: 10.1016/j.vaccine.2015.08.084. Epub 2015 Sep 9.
引用本文的文献
1
Unleashing the power of the BCG vaccine in modulating viral immunity through heterologous protection: A scoping review.通过异源保护释放卡介苗疫苗在调节病毒免疫方面的潜力：一项范围综述。
Hum Vaccin Immunother. 2025 Dec;21(1):2521190. doi: 10.1080/21645515.2025.2521190. Epub 2025 Jul 3.
2
Challenges in developing new tuberculosis vaccines.开发新型结核病疫苗面临的挑战。
Mem Inst Oswaldo Cruz. 2025 Jun 9;120:e240236. doi: 10.1590/0074-02760240236. eCollection 2025.
3
Dendritic Cell Vaccine Harboring Inactivated Mycobacteria Induces Immune Protection Against Tuberculosis in Murine Models and is Well Tolerated in Humans.携带灭活分枝杆菌的树突状细胞疫苗在小鼠模型中诱导抗结核免疫保护，且在人体中耐受性良好。
Small Sci. 2024 Dec 18;5(2):2400355. doi: 10.1002/smsc.202400355. eCollection 2025 Feb.
4
Enhanced Antimicrobial Peptide Response Following Bacillus Calmette-Guerin Vaccination in Elderly Individuals.卡介苗接种后老年个体抗菌肽反应增强
Vaccines (Basel). 2024 Sep 18;12(9):1065. doi: 10.3390/vaccines12091065.
5
The mark of success: The role of vaccine-induced skin scar formation for BCG and smallpox vaccine-associated clinical benefits.成功的标志：疫苗诱导的皮肤瘢痕形成在卡介苗和天花疫苗相关临床获益中的作用。
Semin Immunopathol. 2024 Aug 26;46(5):13. doi: 10.1007/s00281-024-01022-9.
6
Bacillus Calmette-Guérin (BCG) Revaccination and Protection Against Tuberculosis: A Systematic Review.卡介苗（BCG）再接种与结核病预防：一项系统评价
Cureus. 2024 Mar 21;16(3):e56643. doi: 10.7759/cureus.56643. eCollection 2024 Mar.
7
A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice.一种经修饰的卡介苗，其与肽聚糖酰胺化相关的酶被耗尽，可诱导小鼠对结核病的保护作用增强。
Elife. 2024 Apr 19;13:e89157. doi: 10.7554/eLife.89157.
8
Rifampicin Resistance Pattern of Mycobacterium tuberculosis Infection in Tertiary Care Hospital Settings.三级护理医院环境中结核分枝杆菌感染的利福平耐药模式
Cureus. 2024 Mar 7;16(3):e55755. doi: 10.7759/cureus.55755. eCollection 2024 Mar.
9
Novel delivery systems for controlled release of bacterial therapeutics.新型给药系统用于控制细菌治疗药物的释放。
Trends Biotechnol. 2024 Jul;42(7):929-937. doi: 10.1016/j.tibtech.2024.01.002. Epub 2024 Feb 2.
10
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?改进卡介苗再接种策略：是要召回记录，还是干脆称其为凤凰涅槃？
Hum Vaccin Immunother. 2024 Dec 31;20(1):2300158. doi: 10.1080/21645515.2023.2300158. Epub 2024 Jan 29.
本文引用的文献
1
BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.BCG 诱导的乌干达新生儿对异源传染病的非特异性影响：一项研究者盲法随机对照试验。
Lancet Infect Dis. 2021 Jul;21(7):993-1003. doi: 10.1016/S1473-3099(20)30653-8. Epub 2021 Feb 17.
2
BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau.卡介苗接种后 2 个月的皮肤反应与婴儿期更好的生存相关：来自几内亚比绍的一项前瞻性观察研究。
BMJ Glob Health. 2020 Sep;5(9). doi: 10.1136/bmjgh-2020-002993.
3
Mitochondrial Signature in Human Monocytes and Resistance to Infection in During Fumarate-Induced Innate Immune Training.人单核细胞中的线粒体特征与富马酸诱导固有免疫训练期间的感染抗性
Front Immunol. 2020 Aug 5;11:1715. doi: 10.3389/fimmu.2020.01715. eCollection 2020.
4
Circadian rhythm influences induction of trained immunity by BCG vaccination.昼夜节律影响卡介苗接种诱导训练免疫。
J Clin Invest. 2020 Oct 1;130(10):5603-5617. doi: 10.1172/JCI133934.
5
BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner.卡介苗接种以性别依赖的方式抑制人体全身炎症。
J Clin Invest. 2020 Oct 1;130(10):5591-5602. doi: 10.1172/JCI133935.
6
Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against .描述 BCG 诱导的巨噬细胞和中性粒细胞防御机制。
Front Immunol. 2020 Jun 18;11:1202. doi: 10.3389/fimmu.2020.01202. eCollection 2020.
7
BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment.人体卡介苗接种通过造血祖细胞区室诱导训练有素的免疫。
Cell Host Microbe. 2020 Aug 12;28(2):322-334.e5. doi: 10.1016/j.chom.2020.05.014. Epub 2020 Jun 15.
8
The effect of BCG vaccination on alveolar macrophages obtained from induced sputum from healthy volunteers.BCG 疫苗接种对健康志愿者诱导痰中肺泡巨噬细胞的影响。
Cytokine. 2020 Sep;133:155135. doi: 10.1016/j.cyto.2020.155135. Epub 2020 Jun 10.
9
Maternal Latent Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda.母亲潜伏结核感染并不影响婴儿出生时接种卡介苗后的免疫反应：乌干达的一项观察性纵向研究。
Front Immunol. 2020 May 14;11:929. doi: 10.3389/fimmu.2020.00929. eCollection 2020.
10
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.训练免疫：降低 SARS-CoV-2 感染易感性和严重程度的工具。
Cell. 2020 May 28;181(5):969-977. doi: 10.1016/j.cell.2020.04.042. Epub 2020 May 4.
Zotero 插件